drugset / Trial / NCT06138028
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated, single-arm, exploratory clinical study.The study population consisted of treatment naive advanced esophageal squamous cell carcinoma patients. The purpose of this study was to evaluate the efficacy and safety of immunotherapy combined with chemotherapy and residual lesions irradiation of esophageal squamous cell carcinoma.
Timeline
- Start
- 2023-09-20
- Primary completion
- 2025-10-31
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Sintilimab | Monoclonal antibody | — | — |
| Subject | Tocetaxel | Unknown | — | — |